🔎 Trials Near Me

Home › Narcolepsy › Georgia

Pag-aaral pangklinika para sa Narcolepsy sa Georgia

6 pag-aaral para sa Narcolepsy ang naghahanap ng mga kalahok sa mga site sa Georgia.

Mga Lungsod sa Georgia

Opisyal na teksto ng pag-aaral (English)

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

  • Atlanta, Georgia, Atlanta
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07598708

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

  • Alkermes Investigational Site, Macon
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07455383

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

  • Neurotrials Research Inc, Atlanta
  • Sleep Practitioners, LLC, Macon
  • Southeast Lung Associates Research, Rincon
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07675135

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

  • Alkermes Investigational Site, Atlanta
  • Alkermes Investigational Site, Macon
  • Alkermes Investigational Site, Stockbridge
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06767683

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

  • NeuroTrials Research, Inc, Atlanta
  • Sleep Practitioners, LLC, Macon
  • Clinical Research Institute Stockbridge, Stockbridge
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT07493265

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

  • Stockbridge, GA, Atlanta
  • Atlanta, Georgia, Atlanta
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07096674

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.